UW Professor of Medicine, Ganesh Raghu, a Principal Investigator on a Idiopathic Pulmonary Fibrosis Study Wins GrantNovember 1st, 2013 by Sharon O'Hara
UW Professor of Medicine, Ganesh Raghu, and a Principal Investigator on an Idiopathic Pulmonary Fibrosis Study Wins Grant
Ahhh… Dr. Raghu! Urged by my mother to find out what else was wrong with my lungs about 2000, I agreed to visit the University of Washington Medical Center in Seattle to find out. There I met the cheeriest, most enthusiastic and kind pulmonary medical folks I had ever met. If I were dying, as I then believed, I would die with a smile and a grateful, “Doing great, thanks for asking!”
I traveled to the University of Washington Medical Center in Seattle and met the cheery and inquisitive, completely exceptional Dr. Ganesh Raghu and his then sidekick, the irrepressible doc Dr. Raghu designated “Super Fellow,” Christopher H. Goss – a doc who looked beyond patient’s lungs and was instrumental in saving my life years later. Those two and others helped bring this patient back into a positive and living mode – they found the Sarcoidosis evidence through an open lung biopsy – so my emphysema had a new friend occupying lungs and I did not know it. Well…
Dr. Raghu and the other great researchers at the U do brilliant work to help humans around the world. Medical research leads to cures and all manner of exciting stuff for people – today and in tomorrow’s world.
“UW researchers to test novel therapy for idiopathic pulmonary fibrosis
A grant from the NIH will test a promising surgical therapy for treating idiopathic pulmonary fibrosis (IPF), a disease that kills an estimated 100,000 people in the U.S. every year — typically within three to five years of diagnosis. Ganesh Raghu, pictured, UW professor of medicine in the Division of Pulmonary and Critical Care Medicine and a principal investigator on the study, is one of the world’s leading experts on IPF. In 1998, he and his colleagues discovered that 90 percent of patients with IPF had abnormal and asymptomatic acid gastroesophageal reflux. Initial investigations demonstrated to Raghu and co-investigator Carlos Pellegrini, chair of the Department of Surgery, that laparoscopic anti-reflux surgery (LARS) could be a promising treatment for patients with IPF. The NIH’s grant will test this hypothesis by supporting a phase II clinical trial, conducted with 60 volunteer patients from five clinical sites across the U.S., including UW Medicine. “
Congratulations, Dr. Raghu! Rock on!
The old seaman and first mate (me) love you!
Thanks for listening…. Sharon O’Hara
Tags: (LARS), Carlos Pellegrini, chair of the Department of Surgery, Division of Pulmonary and Critical Care Medicine, idiopathic pulmonary fibrosis, NIH, UW Medicine, UW researchers, UWMedical Center